Literature DB >> 21035919

Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients.

Argyris Michalopoulos1, Matthew E Falagas2, Dimitra C Karatza3, Paraskevi Alexandropoulou3, Emmanuel Papadakis3, Leonidas Gregorakos3, George Chalevelakis4, Georgios Pappas5.   

Abstract

BACKGROUND: Characteristics and burden of primary bacteremia because of multidrug-resistant (MDR) gram-negative bacteria (GNB) in intensive care unit (ICU) patients remain understudied.
METHODS: A cohort study of patients with primary MDR GNB-related bacteremia from the ICU of a tertiary Greek hospital during a 3-year period was conducted for recognition of clinical characteristics and risk factors for adverse outcome. A case-control study was further performed to evaluate risk factors for development of MDR GNB-related primary bacteremia.
RESULTS: Fifty monomicrobial episodes of primary bacteremia because of Klebsiella pneumoniae (n = 20), Acinetobacter baumannii (n = 18), and Pseudomonas aeruginosa (n = 12) were recorded. The presence of diabetes mellitus was the only significant risk factor for development of MDR GNB-related primary bacteremia. Most episodes (78%) were ICU acquired in patients with prolonged mechanical ventilation and previous hospitalization in the ward. Mortality was 47.6% vs 19% of controls, P = .01. Mortality was higher in recurrent bacteremia (62.5%). Mortality was statistically associated with age (P = .002) and degree of multiorgan dysfunction expressed by sequential organ failure assessment score on day of bacteremia documentation (P = .001).
CONCLUSION: Critically ill patients with MDR GNB-related primary bacteremia present significant mortality mainly associated with age and multiorgan failure. A baumanii bacteremia confers significant mortality compared with the benign course of K pneumoniae in such settings. Diabetes mellitus is a risk factor for development of such episodes, which may, in part, be general ward acquired, underlining the need for expanded vigilance.
Copyright © 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035919     DOI: 10.1016/j.ajic.2010.06.017

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  19 in total

1.  Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.

Authors:  Mohamed A Jamal; Joel Rosenblatt; Ying Jiang; Ray Hachem; Ann-Marie Chaftari; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 2.  Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.

Authors:  Elisabeth Paramythiotou; Christina Routsi
Journal:  World J Crit Care Med       Date:  2016-05-04

3.  Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?

Authors:  A Touré; P Vanhems; C Lombard-Bohas; J-C Souquet; M Lauverjat; C Chambrier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-22       Impact factor: 3.267

4.  Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis.

Authors:  Linda Chia-Hui Yu; Yi-An Shih; Li-Ling Wu; Yang-Ding Lin; Wei-Ting Kuo; Wei-Hao Peng; Kuo-Shyan Lu; Shu-Chen Wei; Jerrold R Turner; Yen-Hsuan Ni
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

5.  Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine.

Authors:  Mohamed A Jamal; Joel S Rosenblatt; Ray Y Hachem; Jiang Ying; Egbert Pravinkumar; Joseph L Nates; Anne-Marie P Chaftari; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

6.  Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.

Authors:  A Batirel; I I Balkan; O Karabay; C Agalar; S Akalin; O Alici; E Alp; F A Altay; N Altin; F Arslan; T Aslan; N Bekiroglu; S Cesur; A D Celik; M Dogan; B Durdu; F Duygu; A Engin; D O Engin; I Gonen; E Guclu; T Guven; C A Hatipoglu; S Hosoglu; M K Karahocagil; A U Kilic; B Ormen; D Ozdemir; S Ozer; N Oztoprak; N Sezak; V Turhan; N Turker; H Yilmaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267

7.  Development of a Simple Sequential Organ Failure Assessment Score for Risk Assessment of Emergency Department Patients With Sepsis.

Authors:  Faheem W Guirgis; Michael A Puskarich; Carmen Smotherman; Sarah A Sterling; Shiva Gautam; Frederick A Moore; Alan E Jones
Journal:  J Intensive Care Med       Date:  2017-11-15       Impact factor: 3.510

8.  The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection.

Authors:  Erika Ferraz de Gouvêa; Ianick Souto Martins; Marcia Halpern; Adriana Lúcia Pires Ferreira; Samanta Teixeira Basto; Renato Torres Gonçalves; Beatriz Meurer Moreira; Guilherme Santoro-Lopes
Journal:  BMC Infect Dis       Date:  2012-12-13       Impact factor: 3.090

9.  Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia.

Authors:  Swati Patolia; Getahun Abate; Nirav Patel; Setu Patolia; Sharon Frey
Journal:  Ther Adv Infect Dis       Date:  2017-09-12

10.  The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis.

Authors:  Yarden Zohar; Shani Zilberman Itskovich; Shlomit Koren; Ronit Zaidenstein; Dror Marchaim; Ronit Koren
Journal:  Intern Emerg Med       Date:  2020-09-22       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.